The TRPML1 expression is decreased in human non-small cell lung cancer (NSCLC) tissues compared to normal ones, but it increases in advanced stages, suggesting that TRPML1 may confer a survival advantage (32). The gene discussed is MCOLN1; the disease is non-small cell lung carcinoma.